Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Human thymocyte responsiveness to stem cell factor: synergy with interleukin-2 for the generation of NK/LAK cytotoxicity.

Immunology letters - 1 Aug 1996

Uittenbogaart C H, Schmidc I, Kiertscher S, Shau H, Anisman D J, Zsebo K M, Clement L T

Abstract excerpt

Human recombinant stem cell factor (SCF) increases the viability and cell size of a subset of thymocytes in vitro, but does not independently induce phenotypic changes on thymocytes indicative of T cell differentiation. The SCF-responsive thymocytes have characteristics of large granular cells, that do not express T, B or NK cell-related antigens, and are primarily found in immature thymocyte subsets. These large...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD
Share to Cell Differentiation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cells, Cultured

Share to Cytotoxicity, Immunologic

Share to Hematopoietic Stem Cells

Share to Interleukin-2

Share to Phenotype

Source

Identifiers

PMID: 8877418
DOI: 10.1016/0165-2478(96)02580-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Human thymocyte responsiveness to stem cell factor: synergy with interleukin-2 for the generation of NK/LAK cytotoxicity.PMID 8877418Read ↗

Characterization of two novel cell lines, DERL-2 (CD56+/CD3+/Tcry5+) and DERL-7 (CD56+/CD3-/TCRgammadelta-), derived from a single patient with CD56+ non-Hodgkin's lymphoma.Semantic proximity Read ↗

Human spleen and peripheral blood lymphocytes activated by interleukin-2 have similar phenotypic and functional characteristics.Semantic proximity Read ↗

Influence of murine mesenchymal stem cells on proliferation, phenotype, vitality, and cytotoxicity of murine cytokine-induced killer cells in coculture.Semantic proximity Read ↗

TNF-alpha potentiation of the lymphokine-activated killer response of murine thymus cells.Semantic proximity Read ↗

The Synergy Between Stem Cell Factor (SCF) and Granulocyte Colony-stimulating Factor (G-CSF): Molecular Basis and Clinical RelevanceSemantic proximity Read ↗

Characterization of OKT3-initiated lymphokine-activated effectors expanded with interleukin 2 and tumor necrosis factor alpha.Semantic proximity Read ↗

Combined activation of murine lymphocytes with staphylococcal enterotoxin and interleukin-2 results in additive cytotoxic activity.Semantic proximity Read ↗

Generation of natural killer-like cytotoxicity from human thymocytes with interleukin-2.Semantic proximity Read ↗

Identification of a common T/natural killer cell progenitor in human fetal thymus.Semantic proximity Read ↗

NK and LAK activities from human marrow progenitors. I. The effects of interleukin-2 and interleukin-1.Semantic proximity Read ↗

Gamma-irradiated peripheral blood mononuclear cells can express LAK activity.Semantic proximity Read ↗

Lymphokine-activated killer (LAK) cells modulate the effects of IL-2 on a T cell-mediated immune response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.